A delicious, daily alternative to pharmaceuticals in the management of inflammation-related illnesses.
Business overview
Location | London, United Kingdom |
---|---|
Social media | |
Website | kurk.life/ |
Sectors | Food & Beverage Mixed Digital/Non-Digital Mixed B2B/B2C |
Company number | 12680542 |
Incorporation date | 18 Jun 2020 |
Investment summary
Business highlights
- £3.3m+ DTC sales in UK/EU/Australia*
- Fully integrated Biotech, trademarked formulations and IP
- Proven DTC model with 53% repeat rate
- Over 33,000 happy customers in 4 countries
Key features
Idea
Introduction
Pain-killer overuse is a common problem in the developed world, and many inflammatory issues are mistreated. Kurk is a delicious, daily alternative to pharmaceuticals in the management of inflammation-related illnesses (for example, arthritis, inflammatory bowel conditions, skin disorders including acne, cardiovascular disease). Kurk is 100% a natural product made from plants with zero synthetics and our mission is to help millions of people manage common health issues, naturally.
Having each fought and won their own battles with cancer, Dr. Harrison Weisinger and Trent Scanlen together embarked on a personal and professional journey to optimise their health naturally. After studying curcumin - a plant compound in the turmeric plant, the opportunity was clear. Curcumin has breathtaking anti-inflammatory and anti-cancer properties, but is poorly absorbed due to its crystallised form. Research into Curcumin has been booming - rarely is this seen and is an indicator of worldwide interest in this plant compound.

After 4 years of extensive scientific, medical and customer research, across multiple iterations of product development and testing, Kurk was created - our 100% plant-based curcumin drink, designed for maximum taste and absorption.
Using our trademarked MyCelle+™ formulation and manufacturing technology, produced in our own purpose-built lab in Twickenham, we can improve the absorption of difficult plant compounds.
Backed by Tom Hardy, Tinie Tempah and renowned investor Lyndon Lea, we are now looking to increase our investor base and execute on our plan. Our Customers love us and we are proud to have made a real difference in their lives, offering them a natural alternative to standard painkillers.
Monetisation strategy
Kurk is a D2C subscription business with thousands of customers using our products as part of their daily health routine. After years of continual testing, we believe we have developed the optimal product to scale - the crucial combination of a high repeat purchase rate, and IP. We now plan to roll out our proven product into retail and new markets.
We have export opportunities worldwide, and an abundance of interest within the scientific, medical and food industry and have ambitious plans to scale.
We are well positioned across three growing markets:

Having funded this company with Founder + Friend's funds, we believe we have the discipline to operate carefully while at the same time achieving maximal gains. We also have an exciting pipeline of products that are now ready for launch worldwide through retail, online and B2B licensing channels.

Open an account to get access to more details about the Kurk campaign
Already have an account? Log in
To comply with financial regulations, we can only show full campaign details to registered users.
Open an account to get access to more details about the Kurk campaign
Already have an account? Log in
To comply with financial regulations, we can only show full campaign details to registered users.
Open an account to get access to more details about the Kurk campaign
Already have an account? Log in
To comply with financial regulations, we can only show full campaign details to registered users.
Open an account to get access to the team members of Kurk
Already have an account? Log in
To comply with financial regulations, we can only show full campaign details to registered users.
Open an account to get access to the Kurk campaign updates
Already have an account? Log in
To comply with financial regulations, we can only show full campaign details to registered users.
Open an account to get access to the list of investors in the Kurk campaign
Already have an account? Log in
To comply with financial regulations, we can only show full campaign details to registered users.
Open an account and verify your identity to get access to the Kurk discussion
Already have an account? Log in
To comply with financial regulations, we can only show full campaign details to registered users.
Open an account and verify your identity to get access to the Kurk pitch deck and other documents
Already have an account? Log in
To comply with financial regulations, we can only show full campaign details to registered users.